SE7805589L - Forfarande for framstellning av nya derivat av 4-hydroxitiazolidin-2-tion - Google Patents

Forfarande for framstellning av nya derivat av 4-hydroxitiazolidin-2-tion

Info

Publication number
SE7805589L
SE7805589L SE7805589A SE7805589A SE7805589L SE 7805589 L SE7805589 L SE 7805589L SE 7805589 A SE7805589 A SE 7805589A SE 7805589 A SE7805589 A SE 7805589A SE 7805589 L SE7805589 L SE 7805589L
Authority
SE
Sweden
Prior art keywords
hydroxitiazolidin
procedure
preparation
new
thion derivatives
Prior art date
Application number
SE7805589A
Other languages
English (en)
Swedish (sv)
Inventor
J D Bourzat
D Farge
A Leger
G Ponsinet
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7715072A external-priority patent/FR2391212A1/fr
Priority claimed from FR7812185A external-priority patent/FR2424269A2/fr
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of SE7805589L publication Critical patent/SE7805589L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SE7805589A 1977-05-17 1978-05-16 Forfarande for framstellning av nya derivat av 4-hydroxitiazolidin-2-tion SE7805589L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7715072A FR2391212A1 (fr) 1977-05-17 1977-05-17 Nouveaux derives de la thiazolidine, leur preparation et les compositions qui les contiennent
FR7812185A FR2424269A2 (fr) 1978-04-25 1978-04-25 Nouveaux derives de la thiazolidine, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
SE7805589L true SE7805589L (sv) 1978-11-18

Family

ID=26220024

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7805589A SE7805589L (sv) 1977-05-17 1978-05-16 Forfarande for framstellning av nya derivat av 4-hydroxitiazolidin-2-tion

Country Status (17)

Country Link
AT (1) ATA356778A (fr)
AU (1) AU3613778A (fr)
BE (1) BE867128A (fr)
CA (1) CA1093078A (fr)
DE (1) DE2821555A1 (fr)
DK (1) DK214078A (fr)
ES (1) ES469883A1 (fr)
GB (1) GB1586917A (fr)
IE (1) IE46829B1 (fr)
IL (1) IL54735A0 (fr)
IT (1) IT1096219B (fr)
LU (1) LU79663A1 (fr)
NZ (1) NZ187290A (fr)
OA (1) OA05950A (fr)
PT (1) PT68047B (fr)
SE (1) SE7805589L (fr)
SU (1) SU852171A3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2464954A2 (fr) * 1979-09-12 1981-03-20 Rhone Poulenc Ind Nouveaux derives de la thiazolidine, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
LU79663A1 (fr) 1979-02-02
ATA356778A (de) 1981-01-15
IE46829B1 (en) 1983-10-05
AU3613778A (en) 1979-11-22
SU852171A3 (ru) 1981-07-30
DE2821555A1 (de) 1978-11-30
ES469883A1 (es) 1979-09-16
IE780983L (en) 1978-11-17
IT1096219B (it) 1985-08-26
OA05950A (fr) 1981-06-30
NZ187290A (en) 1981-04-24
BE867128A (fr) 1978-11-16
PT68047A (fr) 1978-06-01
IL54735A0 (en) 1978-07-31
GB1586917A (en) 1981-03-25
IT7823473A0 (it) 1978-05-16
DK214078A (da) 1978-11-18
PT68047B (fr) 1979-09-28
CA1093078A (fr) 1981-01-06

Similar Documents

Publication Publication Date Title
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
SE7701460L (sv) Forfarande for framstellning an nya derivat av 1,2-ditiol
NO151895C (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
SE7701459L (sv) Forfarande for framstellning av nya derivat av 1,2-ditiol
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
SE421212B (sv) Forfarande for framstellning av nya derivat av daunorubicin
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7800681L (sv) Forfarande for framstellning av nya derivat av isokinolin
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
SE7805588L (sv) Forfarande for framstellning av nya derivat av 4-hydroxitiazolidin-2-tion
NO780390L (no) Fremgangsmaate for fremstilling av oleandomycin-derivater
SE434266B (sv) Forfarande for framstellning av prostacyklinderivat
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE7811595L (sv) Nya derivat av isokinolin
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
SE7705853L (sv) Forfarande for framstellning av nya derivat av dibenso (de, h ) kinolin
NO771576L (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid
NO149774C (no) Fremgangsmaate for fremstilling av et azetidinon
SE7805589L (sv) Forfarande for framstellning av nya derivat av 4-hydroxitiazolidin-2-tion